Vical to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
September 06 2017 - 3:00PM
Vical Incorporated (Nasdaq:VICL) today announced that the company
will provide an overview of its technologies, development programs,
and outlook on Tuesday, September 12, at 10:50 a.m. ET at the
Rodman & Renshaw 19th Annual Global Investment Conference,
sponsored by H.C. Wainwright & Co., LLC. The conference
is being held on September 10-12, 2017, at Lotte New York
Palace Hotel in New York City. A webcast of the company’s
presentation will be available live and archived through the Events
& Presentations page in the Investors section of the Vical
website at www.vical.com.
About VicalVical develops
biopharmaceutical products for the prevention and treatment of
chronic or life-threatening infectious diseases, based on its
patented DNA delivery technologies and other therapeutic
approaches. Additional information on Vical is available at
www.vical.com.
Contact:
Andrew Hopkins
(858) 646-1127
Website: www.vical.com
Vical (NASDAQ:VICL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From Apr 2023 to Apr 2024